Lawrence Fong, MD of University of California, San Francisco discusses the use of more combinations therapies, like Nivolumab and Ipilimumab. This combination therapy is FDA approved for Melanoma, but combination therapies like these may be used for treating new cancers such as Lung, Bladder, and Kidney. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
More Combinations like Nivolumab and Ipilimumab Coming for Lung, Bladder, and Kidney Cancer
